Silent Cerebral Embolism Following Left Ventricular Endocardial Ablation: The Silver Study
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.70099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Cemalettin Akman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Adıyaman University Training and Research Hospital, Adıyaman, Türkiye. Hauptthemen laut MEDLINE: Catheter Ablation, Ventricular Premature Complexes, Tachycardia, Ventricular, Intracranial Embolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Endocardial ventricular ablation is frequently used to manage premature ventricular complexes (PVCs) and idiopathic ventricular tachycardias (VTs); however, data regarding new silent cerebral embolism (SCE) during this procedure are quite limited. This prospective study sought to determine the incidence and potential risk factors of SCE in patients who underwent left ventricular (LV) ablation for PVCs or idiopathic VTs.
Methods
A total of 37 [male:15 (40.5%), mean age:52.27 ± 14.31years] patients who underwent treatment of endocardial ventricular ablation at our institution between August 2022 and January 2024 were included. Baseline data, arrhythmia characteristics (PVC/VT), and procedural details were prospectively evaluated. The primary endpoint was defined as a new SCE after the procedure. All patients were evaluated with diffusion‐weighted magnetic resonance imaging (DW‐MRI) before and after the procedure within 24 h.
Results
Right ventricular (RV) and LV endocardial ablation was performed in 10 (VT, n = 1, PVC, N = 9) and 27 patients (VT, n = 3, PVC, n = 24), respectively. At least 1 new SCE detected by DW‐MRI was observed in 6 patients (22.2%) in the LV ablation group, while no SCE was detected in the RV ablation group ( p = 0.162). Patients with high CHA₂DS₂‐VASc scores [relative risk (RR): 1.720, p = 0.047] and elevated N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) levels (RR: 1.002, p = 0.013) had a higher risk of SCE among LV ablation patients.
Conclusion
Patients who underwent LV ablation for PVC/VT with high CHA₂DS₂‐VASc scores and elevated NT‐proBNP levels may be at increased risk of SCE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Adıyaman University Training and Research Hospital, Adıyaman, Türkiye.
- Department of Cardiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.
- Department of Radiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.
ORCID-Profile: Cemalettin Akman
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Akman, C., Yıldız, M., Sürgit, Ö., Aydın, S., Öner, E., Güner, A., Karakurt, H., Serbest, N. G., Ertürk, M., Uzun, F., & Other Members of the Silver Study Group (2025). Silent Cerebral Embolism Following Left Ventricular Endocardial Ablation: The Silver Study. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70099
Vancouver
Akman C, Yıldız M, Sürgit Ö, Aydın S, Öner E, Güner A, et al. Silent Cerebral Embolism Following Left Ventricular Endocardial Ablation: The Silver Study. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.70099
BibTeX
@article{Akman2025,
author = {Akman, Cemalettin and Yıldız, Mustafa and Sürgit, Özgür and Aydın, Sinem and Öner, Ender and Güner, Ahmet and Karakurt, Hüseyin and Serbest, Nail Güven and Ertürk, Mehmet and Uzun, Fatih and Other Members of the Silver Study Group, Other Members of the Silver Study Group},
title = {Silent Cerebral Embolism Following Left Ventricular Endocardial Ablation: The Silver Study},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.70099}
}
EUVIMED